Thermo Fisher Scientific | TMO - Equity Capital And Reserves

Stock Price
542.72
Daily Change
0.36 0.07%
Monthly
-12.06%
Yearly
-5.03%
Q1 Forecast
560.79

Thermo Fisher Scientific reported $53.54B in Equity Capital and Reserves for its fiscal quarter ending in December of 2025.





Equity Capital And Reserves Change Date
Abbott USD 50.83B 0 Sep/2025
Agilent USD 6.74B 371M Sep/2025
Becton, Dickinson and Co. USD 25.39B 82M Sep/2025
Bio Techne USD 2.01B 45.18M Dec/2025
Bio-Rad Laboratories USD 6.74B 391.9M Sep/2025
Boston Scientific USD 22.65B 235M Sep/2025
Bruker USD 2.49B 625.6M Sep/2025
Charles River Laboratories USD 3.41B 52.13M Sep/2025
Danaher USD 52.53B 1.46B Dec/2025
Dentsply International USD 1.48B 482M Sep/2025
Edwards Lifesciences USD 10.2B 340.3M Sep/2025
Exact Sciences USD 2.5B 32M Sep/2025
General Electric Aerospace USD 18.9B 86M Dec/2025
Henry Schein USD 3.36B 84M Sep/2025
Hologic USD 5.25B 197.2M Dec/2025
Illumina USD 2.72B 342M Dec/2025
Intuitive Surgical USD 17.82B 894.3M Dec/2025
IQVIA Holdings USD 6.5B 343M Dec/2025
Laboratory Of America USD 8.71B 240.3M Sep/2025
Medtronic USD 47.89B 131M Jun/2025
Mettler Toledo International USD -23.64M 225.56M Dec/2025
Myriad Genetics USD 372.8M 15.3M Sep/2025
Olympus JPY 733.58B 929M Sep/2025
Quest Diagnostics USD 7.26B 30M Sep/2025
Repligen USD 442.96M 1.62B Sep/2025
Revvity USD 7.38B 180.27M Sep/2025
Stryker USD 21.78B 594M Sep/2025
Thermo Fisher Scientific USD 53.54B 2.38B Dec/2025
Veracyte USD 1.26B 36.61M Sep/2025
Waters USD 2.33B 170.88M Sep/2025
Zimmer Biomet Holdings USD 12.77B 231.7M Sep/2025